Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 106

1.

Comparison of pathology sampling protocols for pancreatoduodenectomy specimens.

Grillo F, Ferro J, Vanoli A, Delfanti S, Pitto F, Peñuela L, Bianchi R, Grami O, Fiocca R, Mastracci L.

Virchows Arch. 2019 Dec 4. doi: 10.1007/s00428-019-02687-6. [Epub ahead of print]

PMID:
31802231
2.

Lymph node number, surface area and lymph node ratio are important prognostic indicators in neoadjuvant chemoradiotherapy treated rectal cancer.

Pitto F, Zoppoli G, Scabini S, Romairone E, Fiocca R, Ballestrero A, Sparavigna M, Malaspina L, Valle L, Grillo F, Mastracci L.

J Clin Pathol. 2019 Sep 25. pii: jclinpath-2019-206139. doi: 10.1136/jclinpath-2019-206139. [Epub ahead of print]

PMID:
31554678
3.

Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes.

Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafà R, Giordano G, Pancione M, Grillo F, Mastracci L.

Cancers (Basel). 2019 Jul 23;11(7). pii: E1036. doi: 10.3390/cancers11071036. Review.

4.

Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.

Coati I, Lotz G, Fanelli GN, Brignola S, Lanza C, Cappellesso R, Pellino A, Pucciarelli S, Spolverato G, Guzzardo V, Munari G, Zaninotto G, Scarpa M, Mastracci L, Farinati F, Realdon S, Pilati P, Lonardi S, Valeri N, Rugge M, Kiss A, Loupakis F, Fassan M.

Br J Cancer. 2019 Jul;121(3):257-263. doi: 10.1038/s41416-019-0508-4. Epub 2019 Jun 25.

PMID:
31235864
5.

IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade.

Pistillo MP, Carosio R, Banelli B, Morabito A, Mastracci L, Ferro P, Varesano S, Venè R, Poggi A, Roncella S.

Cell Mol Immunol. 2019 Jun 19. doi: 10.1038/s41423-019-0245-x. [Epub ahead of print] No abstract available.

PMID:
31217525
6.

A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization.

Cangelosi D, Resaz R, Petretto A, Segalerba D, Ognibene M, Raggi F, Mastracci L, Grillo F, Bosco MC, Varesio L, Sica A, Colombo I, Eva A.

J Proteome Res. 2019 Jul 5;18(7):2965-2978. doi: 10.1021/acs.jproteome.9b00309. Epub 2019 Jun 20.

PMID:
31173686
7.

Safety and efficacy of hydroxytyrosol-based formulation on skin inflammation: in vitro evaluation on reconstructed human epidermis model.

Smeriglio A, Denaro M, Mastracci L, Grillo F, Cornara L, Shirooie S, Nabavi SM, Trombetta D.

Daru. 2019 Jun;27(1):283-293. doi: 10.1007/s40199-019-00274-3. Epub 2019 May 26.

8.

Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.

Simbolo M, Barbi S, Fassan M, Mafficini A, Ali G, Vicentini C, Sperandio N, Corbo V, Rusev B, Mastracci L, Grillo F, Pilotto S, Pelosi G, Pelliccioni S, Lawlor RT, Tortora G, Fontanini G, Volante M, Scarpa A, Bria E.

J Thorac Oncol. 2019 Sep;14(9):1651-1661. doi: 10.1016/j.jtho.2019.05.003. Epub 2019 May 11.

9.

Clinico-pathological associations and concomitant mutations of the RAS/RAF pathway in metastatic colorectal cancer.

Isnaldi E, Garuti A, Cirmena G, Scabini S, Rimini E, Ferrando L, Lia M, Murialdo R, Tixi L, Carminati E, Panaro A, Gallo M, Grillo F, Mastracci L, Repetto L, Fiocca R, Romairone E, Zoppoli G, Ballestrero A.

J Transl Med. 2019 Apr 29;17(1):137. doi: 10.1186/s12967-019-1879-2.

10.

Human Engineered Cartilage and Decellularized Matrix as an Alternative to Animal Osteoarthritis Model.

Galuzzi M, Perteghella S, Antonioli B, Tosca MC, Bari E, Tripodo G, Sorrenti M, Catenacci L, Mastracci L, Grillo F, Marazzi M, Torre ML.

Polymers (Basel). 2018 Jul 4;10(7). pii: E738. doi: 10.3390/polym10070738.

11.

Adenocarcinoma With Osseous Metaplasia: Is It Bad to the Bone?

Mastracci L, Ficarra G, Bianchi R, Pesce F, Grillo F.

Int J Surg Pathol. 2019 Apr 8:1066896919842204. doi: 10.1177/1066896919842204. [Epub ahead of print] No abstract available.

PMID:
30955387
12.

Characterization of high- and low-risk hepatocellular adenomas by magnetic resonance imaging in an animal model of glycogen storage disease type 1A.

Resaz R, Rosa F, Grillo F, Basso L, Segalerba D, Puglisi A, Bosco MC, Mastracci L, Neumaier CE, Varesio L, Eva A.

Dis Model Mech. 2019 Apr 5;12(4). pii: dmm038026. doi: 10.1242/dmm.038026.

13.

Abdominal Ectopic Thyroid Tissue: The Man From Istanbul.

Campora M, Trambaiolo Antonelli C, Valle L, Fiocca R, Mastracci L, Grillo F.

Int J Surg Pathol. 2019 Aug;27(5):553-555. doi: 10.1177/1066896919833784. Epub 2019 Mar 14.

PMID:
30871393
14.

Yellow Is the New Black.

Campora M, Cornara L, Paudice M, Mastracci L, Grillo F.

Int J Surg Pathol. 2019 Mar 7:1066896919833168. doi: 10.1177/1066896919833168. [Epub ahead of print] No abstract available.

PMID:
30845864
15.

Agar pre-embedding of small skin biopsies: real-life benefits and challenges in high throughput pathology laboratories.

Ridolfi M, Paudice M, Salvi S, Valle L, Gualco M, Perasole A, Anselmi L, Fiocca R, Mastracci L, Grillo F.

J Clin Pathol. 2019 Jun;72(6):448-451. doi: 10.1136/jclinpath-2018-205680. Epub 2019 Feb 20.

PMID:
30787027
16.

Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin.

Mastracci L, Gambella A, Bragoni A, Pigozzi S, Pastorino L, Vanni I, Tosi I, Campora M, Fiocca R, Grillo F.

Histochem Cell Biol. 2019 Jun;151(6):501-511. doi: 10.1007/s00418-018-1765-7. Epub 2019 Jan 2.

PMID:
30604285
17.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171. Review.

18.

Clear cell dysplasia in a sessile serrated adenoma.

Fassan M, Pennelli G, Mastracci L, Remo A, Cappellesso R, Lo Mele M, Realdon S, Munari G, Lazzi S, Rugge M.

Pathol Res Pract. 2018 Dec;214(12):2121-2122. doi: 10.1016/j.prp.2018.09.020. Epub 2018 Sep 28. No abstract available.

PMID:
30293952
19.

CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients.

Dalmasso B, Pastorino L, Ciccarese G, Andreotti V, Grillo F, Mastracci L, Spagnolo F, Ballestrero A, Queirolo P, Bruno W, Ghiorzo P.

J Am Acad Dermatol. 2019 May;80(5):1263-1271. doi: 10.1016/j.jaad.2018.07.060. Epub 2018 Sep 28.

PMID:
30274933
20.

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine.

Simbolo M, Vicentini C, Mafficini A, Fassan M, Pedron S, Corbo V, Mastracci L, Rusev B, Pedrazzani C, Landoni L, Grillo F, Cingarlini S, Rindi G, Luchini C, Scarpa A, Lawlor RT.

Virchows Arch. 2018 Dec;473(6):709-717. doi: 10.1007/s00428-018-2450-x. Epub 2018 Sep 16.

21.

Histopathologic tumor regression grading in patients with gastric carcinoma submitted to neoadjuvant treatment: results of a Delphi survey.

Tsekrekos A, Detlefsen S, Riddell R, Conner J, Mastracci L, Sheahan K, Shetye J, Lundell L, Vieth M.

Hum Pathol. 2019 Feb;84:26-34. doi: 10.1016/j.humpath.2018.08.028. Epub 2018 Sep 12.

PMID:
30217622
22.

Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.

Bruno W, Martinuzzi C, Dalmasso B, Andreotti V, Pastorino L, Cabiddu F, Gualco M, Spagnolo F, Ballestrero A, Queirolo P, Grillo F, Mastracci L, Ghiorzo P.

Oncotarget. 2018 Jun 19;9(47):28798. doi: 10.18632/oncotarget.25684. eCollection 2018 Jun 19.

23.

Development and characterization of an inducible mouse model for glycogen storage disease type Ib.

Raggi F, Pissavino AL, Resaz R, Segalerba D, Puglisi A, Vanni C, Antonini F, Del Zotto G, Gamberucci A, Marcolongo P, Bosco MC, Grillo F, Mastracci L, Eva A.

J Inherit Metab Dis. 2018 Nov;41(6):1015-1025. doi: 10.1007/s10545-018-0211-2. Epub 2018 Jul 2.

PMID:
29967951
24.

Targeting the Epidermal Growth Factor Receptor Can Counteract the Inhibition of Natural Killer Cell Function Exerted by Colorectal Tumor-Associated Fibroblasts.

Costa D, Venè R, Benelli R, Romairone E, Scabini S, Catellani S, Rebesco B, Mastracci L, Grillo F, Minghelli S, Loiacono F, Zocchi MR, Poggi A.

Front Immunol. 2018 May 29;9:1150. doi: 10.3389/fimmu.2018.01150. eCollection 2018.

25.

HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact.

Murdaca G, Calamaro P, Lantieri F, Pigozzi S, Mastracci L, Grillo F, Magnani O, Ceppa P, Puppo F, Fiocca R.

Virchows Arch. 2018 Oct;473(4):425-433. doi: 10.1007/s00428-018-2379-0. Epub 2018 May 29.

PMID:
29845360
26.

Centrosome Linker-induced Tetraploid Segregation Errors Link Rhabdoid Phenotypes and Lethal Colorectal Cancers.

Remo A, Manfrin E, Parcesepe P, Ferrarini A, Han HS, Mickys U, Laudanna C, Simbolo M, Malanga D, Oliveira DM, Baritono E, Colangelo T, Sabatino L, Giuliani J, Molinari E, Garonzi M, Xumerle L, Delledonne M, Giordano G, Ghimenton C, Lonardo F, D'angelo F, Grillo F, Mastracci L, Viglietto G, Ceccarelli M, Colantuoni V, Scarpa A, Pancione M.

Mol Cancer Res. 2018 Sep;16(9):1385-1395. doi: 10.1158/1541-7786.MCR-18-0062. Epub 2018 May 21.

27.

Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain.

Bellessort B, Bachelot A, Grouthier V, De Lombares C, Narboux-Neme N, Garagnani P, Pirazzini C, Astigiano S, Mastracci L, Fontaine A, Alfama G, Duvernois-Berthet E, Levi G.

J Pain Res. 2018 Apr 10;11:715-725. doi: 10.2147/JPR.S163611. eCollection 2018.

28.

Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations.

Bruno W, Martinuzzi C, Dalmasso B, Andreotti V, Pastorino L, Cabiddu F, Gualco M, Spagnolo F, Ballestrero A, Queirolo P, Grillo F, Mastracci L, Ghiorzo P.

Oncotarget. 2017 Dec 14;9(5):5691-5702. doi: 10.18632/oncotarget.23204. eCollection 2018 Jan 19. Erratum in: Oncotarget. 2018 Jun 19;9(47):28798.

29.

Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm.

Pelosi G, Bianchi F, Dama E, Simbolo M, Mafficini A, Sonzogni A, Pilotto S, Harari S, Papotti M, Volante M, Fontanini G, Mastracci L, Albini A, Bria E, Calabrese F, Scarpa A.

Virchows Arch. 2018 Apr;472(4):567-577. doi: 10.1007/s00428-018-2307-3. Epub 2018 Feb 1.

30.

Erratum to: KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Grillo F, Valle L, Ferone D, Albertelli M, Pia Brisigotti M, Cittadini G, Vanoli A, Fiocca R, Mastracci L.

Endocrine. 2017 Sep;57(3):503. doi: 10.1007/s12020-017-1389-z. No abstract available.

PMID:
28823110
31.

KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?

Grillo F, Valle L, Ferone D, Albertelli M, Brisigotti MP, Cittadini G, Vanoli A, Fiocca R, Mastracci L.

Endocrine. 2017 Sep;57(3):494-502. doi: 10.1007/s12020-017-1364-8. Epub 2017 Jul 19. Erratum in: Endocrine. 2017 Aug 19;:.

PMID:
28726181
32.

Quality control in diagnostic immunohistochemistry: integrated on-slide positive controls.

Bragoni A, Gambella A, Pigozzi S, Grigolini M, Fiocca R, Mastracci L, Grillo F.

Histochem Cell Biol. 2017 Nov;148(5):569-573. doi: 10.1007/s00418-017-1596-y. Epub 2017 Jul 17.

PMID:
28714056
33.

Stromal Vascular Fraction Loaded Silk Fibroin Mats Effectively Support the Survival of Diabetic Mice after Pancreatic Islet Transplantation.

Perteghella S, Vigani B, Mastracci L, Grillo F, Antonioli B, Galuzzi M, Tosca MC, Crivelli B, Preda S, Tripodo G, Marazzi M, Chlapanidas T, Torre ML.

Macromol Biosci. 2017 Sep;17(9). doi: 10.1002/mabi.201700131. Epub 2017 Jul 10.

PMID:
28691373
34.

Immunohistochemistry on old archival paraffin blocks: is there an expiry date?

Grillo F, Bruzzone M, Pigozzi S, Prosapio S, Migliora P, Fiocca R, Mastracci L.

J Clin Pathol. 2017 Nov;70(11):988-993. doi: 10.1136/jclinpath-2017-204387. Epub 2017 Jun 8.

PMID:
28596153
35.

Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' reply.

Mastracci L, Fiocca R, Engstrom C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L.

Aliment Pharmacol Ther. 2017 Jul;46(1):73-74. doi: 10.1111/apt.14118. No abstract available.

36.

The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery.

Mastracci L, Fiocca R, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L.

Aliment Pharmacol Ther. 2017 May;45(10):1339-1349. doi: 10.1111/apt.14038. Epub 2017 Mar 21.

37.

Seeds in the appendix: a 'fruitful' exploration.

Campora M, Trambaiolo Antonelli C, Grillo F, Bragoni A, Cornara L, Migliora P, Pigozzi S, Mastracci L.

Histopathology. 2017 Aug;71(2):322-325. doi: 10.1111/his.13211. Epub 2017 May 10. No abstract available.

PMID:
28295494
38.

Clear cell colorectal carcinoma: Time to clarify diagnosis.

Remo A, Grillo F, Mastracci L, Fassan M, Sina S, Zanella C, Parcesepe P, Damiano Urso E, Pancione M, Bortuzzo G, Scarpa A, Manfrin E.

Pathol Res Pract. 2017 May;213(5):447-452. doi: 10.1016/j.prp.2017.02.013. Epub 2017 Feb 24. Review.

PMID:
28285963
39.

Section detachment in immunohistochemistry: causes, troubleshooting, and problem-solving.

Gambella A, Porro L, Pigozzi S, Fiocca R, Grillo F, Mastracci L.

Histochem Cell Biol. 2017 Jul;148(1):95-101. doi: 10.1007/s00418-017-1558-4. Epub 2017 Mar 11.

PMID:
28285337
40.

Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice.

Astigiano S, Puglisi A, Mastracci L, Fais S, Barbieri O.

J Enzyme Inhib Med Chem. 2017 Dec;32(1):363-368. doi: 10.1080/14756366.2016.1252760.

41.

Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry.

Bruno W, Martinuzzi C, Andreotti V, Pastorino L, Spagnolo F, Dalmasso B, Cabiddu F, Gualco M, Ballestrero A, Bianchi-Scarrà G, Queirolo P, Grillo F, Mastracci L, Ghiorzo P; Italian Melanoma Intergroup (IMI).

Oncotarget. 2017 Jan 31;8(5):8069-8082. doi: 10.18632/oncotarget.14094.

42.

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.

Simbolo M, Mafficini A, Sikora KO, Fassan M, Barbi S, Corbo V, Mastracci L, Rusev B, Grillo F, Vicentini C, Ferrara R, Pilotto S, Davini F, Pelosi G, Lawlor RT, Chilosi M, Tortora G, Bria E, Fontanini G, Volante M, Scarpa A.

J Pathol. 2017 Mar;241(4):488-500. doi: 10.1002/path.4853. Epub 2016 Dec 29.

43.

Epithelial Thickness is a Marker of Gastroesophageal Reflux Disease.

Vieth M, Mastracci L, Vakil N, Dent J, Wernersson B, Baldycheva I, Wissmar J, Ruth M, Fiocca R.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1544-1551.e1. doi: 10.1016/j.cgh.2016.06.018. Epub 2016 Jun 29.

PMID:
27374007
44.

A Never Ending Journey: Ectopic Thyroid.

Campora M, Trambaiolo Antonelli C, Mastracci L, Pigozzi S, Grillo F.

Int J Surg Pathol. 2017 May;25(3):241-242. doi: 10.1177/1066896916672334. Epub 2016 Oct 5. No abstract available.

PMID:
27708181
45.

HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.

Grillo F, Fassan M, Sarocchi F, Fiocca R, Mastracci L.

World J Gastroenterol. 2016 Jul 14;22(26):5879-87. doi: 10.3748/wjg.v22.i26.5879. Review.

46.

Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation Status.

Cea M, Cagnetta A, Acharya C, Acharya P, Tai YT, Yang C, Lovera D, Soncini D, Miglino M, Fraternali-Orcioni G, Mastracci L, Nencioni A, Montecucco F, Monacelli F, Ballestrero A, Hideshima T, Chauhan D, Gobbi M, Lemoli RM, Munshi N, Treon SP, Anderson KC.

Clin Cancer Res. 2016 Dec 15;22(24):6099-6109. Epub 2016 Jun 10.

47.

Residual tumor micro-foci and overwhelming regulatory T lymphocyte infiltration are the causes of bladder cancer recurrence.

Parodi A, Traverso P, Kalli F, Conteduca G, Tardito S, Curto M, Grillo F, Mastracci L, Bernardi C, Nasi G, Minaglia F, Simonato A, Carmignani G, Ferrera F, Fenoglio D, Filaci G.

Oncotarget. 2016 Feb 9;7(6):6424-35. doi: 10.18632/oncotarget.7024.

48.

Heterogeneous Her2/Neu expression in gastric and gastroesophageal cancer.

Grillo F, Fassan M, Fiocca R, Mastracci L.

Hum Pathol. 2016 Feb;48:173-4. doi: 10.1016/j.humpath.2015.08.023. Epub 2015 Oct 29. No abstract available.

PMID:
26688559
49.

Segmental infarction of the testis: can frozen sections avoid orchidectomy?

Pacella E, Grillo F, Lapetina C, Cabiddu F, Auriati L, Tunesi G, Mastracci L.

Pathologica. 2015 Mar;107(1):22-3.

PMID:
26591628
50.

Advances in pharmacotherapy for treating endometriosis.

Tafi E, Leone Roberti Maggiore U, Alessandri F, Bogliolo S, Gardella B, Vellone VG, Grillo F, Mastracci L, Ferrero S.

Expert Opin Pharmacother. 2015;16(16):2465-83. doi: 10.1517/14656566.2015.1085510. Epub 2015 Sep 7. Review.

PMID:
26569155

Supplemental Content

Loading ...
Support Center